Comparing the 205 patients with evaluable 1p status, cases with 1p deletion were associated with established prognostic factors MYCN amplification, metastatic disease and COG high risk status (P < 0.001, P = 0.065, and P = 0.012, respectively, Table 1). Here, MYCN is linked to metastatic neoplasm.